Pay in 4 interest-free payments of $6.18 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
At 52 weeks, patients previously treated with tirzepatide maintained 74.7% of prior weight loss with orforglipron versus 49.2% with placebo, while those previously treated with semaglutide maintained 79.3% of prior weight loss with orforglipron versus 37.6% with placebo
Mark mentally or physically which areas need rest
These medications have become popular for those struggling with obesity or type 2 diabetes, as they not only improve blood sugar levels but also lead to significant weight loss by helping patients feel more satiated
Looking ahead, employers may continue to face the competing pressures of employee demand for GLP-1 drugs and concerns about costs
US$ 28.82
US$ 29.46
US$ 21.68
